
Sreenivasa S Jonnalagadda MD
Advanced Endoscopic Interventional, Biliary Tract Disease, Esophagus Disease, Gastrointestinal Cancer
Chief, Gastroenterology, Saint Luke’s Hospital of Kansas City Professor of Medicine, UMKC
Join to view full profile
4321 Washington StSte 5100Kansas City, MO 64111
Phone+1 913-491-9100
Fax+1 913-491-9135
Dr. Jonnalagadda is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Missouri-Kansas City School of MedicineFellowship, Gastroenterology, 1995 - 1997
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 1992 - 1995
Goa Medical CollegeClass of 1988
Certifications & Licensure
KS State Medical License 2012 - 2027
MO State Medical License 1995 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013, 2015-2017
Clinical Trials
- Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients Start of enrollment: 2005 Aug 12
- Registry Study - Whipple at the Splenic Artery Start of enrollment: 2010 Sep 20
- Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures
Publications & Presentations
PubMed
- Large-caliber endoscopic balloon dilation in patients with persistent dysphagia after magnetic sphincter augmentation (MSA) is safe and may reduce the need for subsequ...Ifrah Fatima, Mir Zulqarnain, Noor Hassan, Mohamed Ahmed, Abbas Bader
Surgical Endoscopy. 2026-08-13 - 1 citationsDouble Whammy: A Case Report of Immune Checkpoint Inhibitor Colitis and ConcomitantColitis in a Patient on Nivolumab.Misha Gautam, Vinay Jahagirdar, Himil Mahadevia, Kimberly Sanders, John P Campbell
ACG Case Reports Journal. 2025-01-01 - 3 citationsThe Bethesda ERCP Skills Assessment Tool (BESAT) can reliably differentiate endoscopists of different experience levels.Kevin Liu, B Joseph Elmunzer, Sachin Wani, Tiffany Taft, Catharine M Walsh
Endoscopy International Open. 2024-02-01
Journal Articles
- Randomized Sham-Controlled Trial of the Six-Month Swallowable Gas-Filled Intragastric Balloon System for Weight LossSteven Edmundowicz, Tarek Hassanein, Vafa Shayani, Mark Noar, George Eid, Sreenivasa S Jonnalagadda, Dennis S Riff, Dayna Early, Anna R Ibele, Matthew D Spann, Kumar K..., Surgery for Obesity and Related Diseases
Authored Content
- Randomized Sham-Controlled Trial of the Six-Month Swallowable Gas-Filled Intragastric Balloon System for Weight LossSeptember 2018
- Mo1285 LUMEN APPOSING SELF EXPANDING METAL STENTS HAVE A HIGHER RATE OF LONG TERM COMPLICATIONS COMPARED TO DOUBLE PIG-TAIL STENTS IN MANAGEMENT OF WALLED OFF PANCREATIC NECROSIS: A MULTICENTER EXPERIENCEMay 2018
- Mo1285 LUMEN APPOSING SELF EXPANDING METAL STENTS HAVE A HIGHER RATE OF LONG TERM COMPLICATIONS COMPARED TO DOUBLE PIG-TAIL STENTS IN MANAGEMENT OF WALLED OFF PANCREATIC NECROSIS: A MULTICENTER EXPERIENCEMay 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: